Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
27. October 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9126
Articles 1 - 20 / 182505
Early Dynamic (18)F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study.
Medicina (Kaunas)
Saylam B, Temelli B, Nebio, Efesoy O, Bozlu M.
PMID: 42942552 [PubMed - as supplied by publisher]
CPTAC Consensus Subtypes Add No Incremental Prognostic Value Beyond Stage and Grade in Clear Cell Renal Cell Carcinoma: A Proteomic Reanalysis.
Life (Basel)
Yasar S, Yagin FH, Alzakari SA, Alkhalifa AK, Al-Hashem F, Tabnjh AK.
PMID: 42942338 [PubMed - as supplied by publisher]
Dosimetric Validation of Ethos Online Adaptive Radiotherapy for Prostate Cancer: An End-to-End Phantom Study.
Life (Basel)
Janiszewska M, Raczkowski M.
PMID: 42942278 [PubMed - as supplied by publisher]
Special Issue: Prostate Cancer Research Update: Molecular Diagnostic Biomarkers.
Int J Mol Sci
Baryshev M.
PMID: 42942079 [PubMed - as supplied by publisher]
Potential Molecular Links Between Triclosan Exposure and Prostate Cancer: An Integrative Computational Analysis.
Int J Mol Sci
You H, Zou Y, Liu J, Xiao Y, Li J, Xu J, Xu W.
PMID: 42941926 [PubMed - as supplied by publisher]
G Protein-Coupled Receptors in Prostate Cancer: Pathophysiological Implications and Potential for Innovative Therapeutics.
Int J Mol Sci
Sarmento-Cabral A, Herrero-Aguayo V, Sáez-Martínez P, Alors-Pérez E, León-González AJ, López-Cánovas JL, Montero-Hidalgo AJ, Gahete MD, Jiménez-Vacas JM, Luque RM.
PMID: 42941869 [PubMed - as supplied by publisher]
Urinary Metabolomics in Bladder Cancer: A Scoping Review of Current Evidence and Translation Implications.
Int J Mol Sci
Carapito Â, Amaro F, Roque AC, Carvalho F, Pinto J, Guedes de Pinho P.
PMID: 42941758 [PubMed - as supplied by publisher]
Current State of Adjuvant Hormone Therapy in Prostate Cancer and in the Management of Pelvic Nodal Recurrence: A Narrative Review.
J Clin Med
D'Andrea B, Montagna A, Benevento I, Rago L, Metallo V, Morano G, Romaniello M, Possidente F, De Fina V, Bianculli A, Lerose RMC, Mazzoccoli C, Telesca D, Storto G, Gallicchio R, Lazzari G.
PMID: 42941560 [PubMed - as supplied by publisher]
Real-World PSA Response and Safety Outcomes of 177Lu-PSMA-617 in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Validation Study.
J Clin Med
Choi JH, Kim CG, Oh KT, Heo JE, Lee J, Jang WS, Lee SH, Choi YD, Beom SH, Kang WJ, Han WK, Han H.
PMID: 42941282 [PubMed - as supplied by publisher]
VGLL4 Suppresses Malignant Phenotypes of Clear Cell Renal Cell Carcinoma Cells Through Modulation of Hippo/YAP and Wnt/β-Catenin Signaling Pathways.
Biomedicines
Zhang Y, Wang S, Zhao Z, Yuan T, Zhu C, Zhong L.
PMID: 42940140 [PubMed]
Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression.
Biomedicines
Yuan J, Zhan P, Liu J, Lu G, Wang H, Xiao M, Li D.
PMID: 42940099 [PubMed]
Optimized Feature Engineering and Machine Learning Approaches for Early Prediction of Renal Cell Carcinoma.
Cancers (Basel)
Chankhore N, Vora D, Barsocchi P, Bhoi AK.
PMID: 42938916 [PubMed]
Active Surveillance in Low- and Intermediate-Risk Prostate Cancer: Comparative Oncologic Safety, Patient Selection, and Predictors of Treatment Conversion in the Era of Multiparametric MRI: A Systematic Review and Meta-Analysis.
Cancers (Basel)
Konieczny H, Kruk A, Salagierski M.
PMID: 42938910 [PubMed]
REDD1 in Clear Cell Renal Cell Carcinoma: Linking Stress Adaptation, Proteostasis and Therapeutic Resistance.
Cancers (Basel)
Sureshkumar S, Espitia CM, Bi F, Xiong R, Gamble ME, Hakim NL, Kelly KR, Carew JS, Nawrocki ST.
PMID: 42938890 [PubMed]
Molecular Biomarker Testing in Kidney Cancer: Integrating Diagnosis, Prediction, and Emerging Renal Tumor Entities.
Cancers (Basel)
Yaprak Bayrak B, Ozsagir E, Y, Teke K, Cheng M, Caliò A, Martignoni G, Akgul M, Cheng L.
PMID: 42938874 [PubMed]
Lipid Mediators as Therapeutic Targets in Prostate Cancer.
Cancers (Basel)
Balijepalli P, Meier KE.
PMID: 42938850 [PubMed]
Comparative Neoplasm Risk of Mirabegron and Antimuscarinic Therapy in Overactive Bladder: A Multicenter Target Trial Emulation.
Cancers (Basel)
Yen FS, Wei JC, Hsu CC, Hwu CM, Hung YM, Chang R, Lin TP.
PMID: 42938816 [PubMed]
Prostate Cancer Research in Ghana: A Scoping Review of Research Direction and Priorities.
Cancers (Basel)
Amoah I, Anie HA, Tetteh D, Adu Sarpong V, Appiah KAA, Tawiah P.
PMID: 42938786 [PubMed]
Primary renal diffuse large B cell lymphoma misdiagnosed as renal cell carcinoma: A case report.
Medicine (Baltimore)
Li X, Li J, Sun S, Huang P.
PMID: 42937761 [PubMed - indexed for MEDLINE]
Prognostic value of the hemoglobin, albumin, lymphocyte, and platelet score in nonmetastatic renal cell carcinoma after nephrectomy.
Medicine (Baltimore)
Huang Z, Chen D.
PMID: 42937715 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 182505
Page 1 of 9126
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy